GB8606762D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB8606762D0
GB8606762D0 GB868606762A GB8606762A GB8606762D0 GB 8606762 D0 GB8606762 D0 GB 8606762D0 GB 868606762 A GB868606762 A GB 868606762A GB 8606762 A GB8606762 A GB 8606762A GB 8606762 D0 GB8606762 D0 GB 8606762D0
Authority
GB
United Kingdom
Prior art keywords
compaction
ibuprofen
composition
therapeutic agents
crystalline ibuprofen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB868606762A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Priority to GB868606762A priority Critical patent/GB8606762D0/en
Publication of GB8606762D0 publication Critical patent/GB8606762D0/en
Priority to DE8787301825T priority patent/DE3771544D1/de
Priority to AT87301825T priority patent/ATE65393T1/de
Priority to GB8704987A priority patent/GB2187952B/en
Priority to EP87301825A priority patent/EP0241126B1/en
Priority to NZ219560A priority patent/NZ219560A/xx
Priority to IN174/MAS/87A priority patent/IN163939B/en
Priority to IL81884A priority patent/IL81884A0/xx
Priority to FI871112A priority patent/FI871112A7/fi
Priority to ZA871836A priority patent/ZA871836B/xx
Priority to DD87300859A priority patent/DD263232A5/de
Priority to DK136487A priority patent/DK136487A/da
Priority to KR870002431A priority patent/KR870008582A/ko
Priority to CS871827A priority patent/CS182787A2/cs
Priority to JP62063658A priority patent/JPS62230723A/ja
Priority to NO871120A priority patent/NO871120L/no
Priority to HU871184A priority patent/HU195422B/hu
Priority to PL1987264695A priority patent/PL264695A1/xx
Priority to AU70177/87A priority patent/AU7017787A/en
Priority to PT84526A priority patent/PT84526B/pt
Priority to YU00470/87A priority patent/YU47087A/xx
Priority to CN198787101974A priority patent/CN87101974A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polyurethanes Or Polyureas (AREA)
GB868606762A 1986-03-19 1986-03-19 Therapeutic agents Pending GB8606762D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GB868606762A GB8606762D0 (en) 1986-03-19 1986-03-19 Therapeutic agents
DE8787301825T DE3771544D1 (de) 1986-03-19 1987-03-03 Ibupropfen-kristallaggregate enthaltendes arzneimittel.
AT87301825T ATE65393T1 (de) 1986-03-19 1987-03-03 Ibupropfen-kristallaggregate enthaltendes arzneimittel.
GB8704987A GB2187952B (en) 1986-03-19 1987-03-03 Therapeutic agents
EP87301825A EP0241126B1 (en) 1986-03-19 1987-03-03 Pharmaceutical composition comprising aggregates of crystals of ibuprofen
NZ219560A NZ219560A (en) 1986-03-19 1987-03-10 Solid pharmaceutical compositions containing ibuprofen
IN174/MAS/87A IN163939B (en:Method) 1986-03-19 1987-03-12
IL81884A IL81884A0 (en) 1986-03-19 1987-03-13 Ibuprofen compositions
FI871112A FI871112A7 (fi) 1986-03-19 1987-03-13 Terapeuttisia aineita.
ZA871836A ZA871836B (en) 1986-03-19 1987-03-13 Therapeutic agents
DK136487A DK136487A (da) 1986-03-19 1987-03-17 Farmaceutisk praeparat indeholdende ibuprofen og fremgangsmaade til fremstilling deraf
DD87300859A DD263232A5 (de) 1986-03-19 1987-03-17 Therapeutische mittel
KR870002431A KR870008582A (ko) 1986-03-19 1987-03-18 치료제의 제조방법
CS871827A CS182787A2 (en) 1986-03-19 1987-03-18 Method of ibuprophen granules preparation
JP62063658A JPS62230723A (ja) 1986-03-19 1987-03-18 イブプロフエン含有医薬組成物
NO871120A NO871120L (no) 1986-03-19 1987-03-18 Fremgangsmaate for fremstilling av et fast farmasoeytisk preparat.
HU871184A HU195422B (en) 1986-03-19 1987-03-18 Process for producing ibuprofene granules
PL1987264695A PL264695A1 (en) 1986-03-19 1987-03-18 Method for manufacturing a pharmaceutical composition
AU70177/87A AU7017787A (en) 1986-03-19 1987-03-19 Solid pharmaceutical composition of granules of crystalline aggregates of ibuprofen
PT84526A PT84526B (pt) 1986-03-19 1987-03-19 Processo para a preparacao de uma composicao solida compreendendo granulos consistindo essencialmente de um agregado de cristais de ibuprofeno
YU00470/87A YU47087A (en) 1986-03-19 1987-03-19 Process for obtaining granulous ibuprophene
CN198787101974A CN87101974A (zh) 1986-03-19 1987-03-19 治疗剂

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868606762A GB8606762D0 (en) 1986-03-19 1986-03-19 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB8606762D0 true GB8606762D0 (en) 1986-04-23

Family

ID=10594868

Family Applications (2)

Application Number Title Priority Date Filing Date
GB868606762A Pending GB8606762D0 (en) 1986-03-19 1986-03-19 Therapeutic agents
GB8704987A Revoked GB2187952B (en) 1986-03-19 1987-03-03 Therapeutic agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB8704987A Revoked GB2187952B (en) 1986-03-19 1987-03-03 Therapeutic agents

Country Status (21)

Country Link
EP (1) EP0241126B1 (en:Method)
JP (1) JPS62230723A (en:Method)
KR (1) KR870008582A (en:Method)
CN (1) CN87101974A (en:Method)
AT (1) ATE65393T1 (en:Method)
AU (1) AU7017787A (en:Method)
CS (1) CS182787A2 (en:Method)
DD (1) DD263232A5 (en:Method)
DE (1) DE3771544D1 (en:Method)
DK (1) DK136487A (en:Method)
FI (1) FI871112A7 (en:Method)
GB (2) GB8606762D0 (en:Method)
HU (1) HU195422B (en:Method)
IL (1) IL81884A0 (en:Method)
IN (1) IN163939B (en:Method)
NO (1) NO871120L (en:Method)
NZ (1) NZ219560A (en:Method)
PL (1) PL264695A1 (en:Method)
PT (1) PT84526B (en:Method)
YU (1) YU47087A (en:Method)
ZA (1) ZA871836B (en:Method)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3833448A1 (de) * 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
NZ234587A (en) * 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
CA2063141C (en) * 1989-08-04 1997-03-04 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5191114A (en) * 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
AU1193092A (en) * 1992-01-10 1993-08-03 Obschestvo S Ogranichennoi Otvetstvennostju Meditsinsky Nauchno-Proizvodstvenny Komplex Biotiki Granulated pharmaceutical composition and method of obtaining it
EG20677A (en) * 1993-10-01 1999-11-30 Astra Ag Method and an apparatus for micronizing the particle size
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
FR2804603B1 (fr) * 2000-02-04 2004-01-23 Rhodia Chimie Sa Procede continu pour formuler sous forme de granules une ou plusieurs matieres actives pharmaceutiques
DE102005037630A1 (de) 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
JPS60120616A (ja) * 1983-12-05 1985-06-28 Yaskawa Electric Mfg Co Ltd プリセット型可逆カウンタ装置
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing

Also Published As

Publication number Publication date
PT84526B (pt) 1989-11-10
IN163939B (en:Method) 1988-12-10
GB2187952B (en) 1990-05-09
FI871112L (fi) 1987-09-20
GB8704987D0 (en) 1987-04-08
NO871120D0 (no) 1987-03-18
PL264695A1 (en) 1988-05-12
ZA871836B (en) 1987-09-02
EP0241126A1 (en) 1987-10-14
YU47087A (en) 1988-04-30
IL81884A0 (en) 1987-10-20
EP0241126B1 (en) 1991-07-24
PT84526A (en) 1987-04-01
KR870008582A (ko) 1987-10-19
DK136487D0 (da) 1987-03-17
NZ219560A (en) 1989-05-29
HU195422B (en) 1988-05-30
AU7017787A (en) 1987-09-24
DD263232A5 (de) 1988-12-28
FI871112A0 (fi) 1987-03-13
GB2187952A (en) 1987-09-23
DK136487A (da) 1987-09-20
FI871112A7 (fi) 1987-09-20
DE3771544D1 (de) 1991-08-29
NO871120L (no) 1987-09-21
JPS62230723A (ja) 1987-10-09
CS182787A2 (en) 1991-05-14
HUT42939A (en) 1987-09-28
CN87101974A (zh) 1987-10-21
ATE65393T1 (de) 1991-08-15

Similar Documents

Publication Publication Date Title
GB2187952B (en) Therapeutic agents
ZA921659B (en) Low dose dry pharmaceutical preparations
ATE49347T1 (de) Arzneiformen zur oralen verabreichung.
PT76990B (en) Process for preparing tablets by a modified "wet-granulation" technique
FR2571364B1 (fr) Nouveau procede de preparation de nitroparaphenylenediamines n,n'-disubstituees, nouvelles oxazolidones utilisees dans ce procede, nouvelles nitroparaphenylenediamines n,n'-disubstituees obtenues selon ce procede et compositions tinctoriales contenant les nitroparaphenylenediamines n,n'-disubstituees obtenues selon ledit procede
IL88529A (en) Pharmaceutical composition containing a tetracycline and its preparation
HUT34345A (en) Process for producing tablets with controlled dissolution of active ingredients independent of ph
DE3266072D1 (en) Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
ES2043210T3 (es) Forma solida de medicamento con elevado contenido de verapamil.
JPS54130475A (en) Treating method for industrial waste matter containing noxious contaminated substance
TH42148A (th) เม็ดพารอกซิทินและขบวนการเตรียมสิ่งนั้น
TH20826B (th) เม็ดพารอกซิทินและขบวนการเตรียมสิ่งนั้น